These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 18025243)
1. TWEAK/Fn14 interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. Zhao Z; Burkly LC; Campbell S; Schwartz N; Molano A; Choudhury A; Eisenberg RA; Michaelson JS; Putterman C J Immunol; 2007 Dec; 179(11):7949-58. PubMed ID: 18025243 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296 [TBL] [Abstract][Full Text] [Related]
3. TWEAK stimulation of kidney resident cells in the pathogenesis of graft versus host induced lupus nephritis. Molano A; Lakhani P; Aran A; Burkly LC; Michaelson JS; Putterman C Immunol Lett; 2009 Aug; 125(2):119-28. PubMed ID: 19573558 [TBL] [Abstract][Full Text] [Related]
4. Fn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway. Min HK; Kim SM; Park JS; Byun JK; Lee J; Kwok SK; Park YW; Cho ML; Park SH J Transl Med; 2016 Apr; 14():98. PubMed ID: 27098560 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis. Liu ZC; Zhou QL Inflamm Res; 2012 Apr; 61(4):277-84. PubMed ID: 22297307 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway. Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591 [TBL] [Abstract][Full Text] [Related]
8. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis. Chen J; Wei L; Xia Y Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399 [TBL] [Abstract][Full Text] [Related]
9. TWEAK as a target for therapy in systemic lupus erythematosus. Leng RX; Pan HF; Qin WZ; Wang C; Chen LL; Tao JH; Ye DQ Mol Biol Rep; 2011 Jan; 38(1):587-92. PubMed ID: 20358293 [TBL] [Abstract][Full Text] [Related]
11. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity. Campbell S; Michaelson J; Burkly L; Putterman C Front Biosci; 2004 Sep; 9():2273-84. PubMed ID: 15353286 [TBL] [Abstract][Full Text] [Related]
12. Fn14 in podocytes and proteinuric kidney disease. Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007 [TBL] [Abstract][Full Text] [Related]
14. Emerging role of TWEAK-Fn14 axis in lupus, a disease related to autoimmunity and fibrosis. Xu Y; Wei HT; Jing HY; Tan XY; Zhou XT; Ma YR Int J Rheum Dis; 2022 Jan; 25(1):21-26. PubMed ID: 34716660 [TBL] [Abstract][Full Text] [Related]
15. TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Gao HX; Campbell SR; Burkly LC; Jakubowski A; Jarchum I; Banas B; Saleem MA; Mathieson PW; Berman JW; Michaelson JS; Putterman C Cytokine; 2009 Apr; 46(1):24-35. PubMed ID: 19233685 [TBL] [Abstract][Full Text] [Related]
16. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200 [TBL] [Abstract][Full Text] [Related]